Baricitinib Impurity 129 CAS 3043892-25-4
| CAS No. | 3043892-25-4 |
| Molecular Formula | C10H15BN4O4S |
| Molecular Weight | 298.13 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Baricitinib Impurity 129.
CATO supplies Baricitinib Impurity 129 (CAS 3043892-25-4), a pharmacopoeial impurity reference standard (molecular formula C10H15BN4O4S, MW 298.13 g/mol) used for the identification and quantification of trace impurities in APIs.
Based on its molecular formula C10H15BN4O4S, Baricitinib Impurity 129 contains a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 298.13 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Baricitinib Impurity 129 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C10H15BN4O4S |
| Molecular Weight | 298.13 g/mol |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 5.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2005 |
| Nitrogen Atoms | 4 |
| Sulfur Atoms | 1 |
Related Baricitinib Standards
- Baricitinib Impurity 48 (CAS CATO-C4X-226048)
- Baricitinib Impurity 93 (CAS CATO-C4X-226093)
- Baricitinib Impurity 110 (CAS CATO-C4X-2260110)
- Baricitinib Impurity 41 (CAS CATO-C4X-226041)
- Baricitinib Impurity 42 (CAS 1146629-77-7)
- Baricitinib Impurity 109 (CAS CATO-C4X-2260109)
- Baricitinib Impurity 122 (CAS CATO-C4X-2260122)
- Baricitinib Impurity 124 (CAS CATO-C4X-2260124)
Recommended Standards
- N-(4-Chlorophenyl)-2-(6-chloropyridazin-3-yl)hydrazinecarboxamide (CAS 87977-20-6)
- Carteolol Impurity 35 (CAS CATO-C4X-228735)
- N-(4-bromo-3-methylphenyl)-5,6-dihydro-1,4-dioxine-2-carboxamide (CAS 903253-32-7)
- Carteolol impurity 36 (CAS CATO-C4X-228736)
- Candesartan N1-Ethyl Impurity (CAS 1246817-38-8)
- Tegoprazan Impurity 130 (CAS CATO-C4X-2297130)
- Azelastine Impurity 27 HCl (CAS 19869-42-2)
- tert-butyl 2-(hydroxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate (CAS 1251002-29-5)
- (E)-N-{[5-(4-chlorophenyl)furan-2-yl]methylidene}hydroxylamine 2G-046 52507-66-1 (CAS 52507-66-1)
- tert-butyl N-[(5-cyanothiophen-2-yl)methyl]carbamate (CAS 302341-67-9)
- 1-Bromo-4-(difluoromethyl)-2-nitrobenzene (CAS 1261614-43-0)
- 4-Ethynyl-1-methylpiperidine (CAS 91324-39-9)
- 2-(5-(Hydroxymethyl)pyridin-3-yl)benzonitrile (CAS 1346691-53-9)
- Ephrin-A2-Selective YSA-Peptide (CAS 532441-10-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com